206 related articles for article (PubMed ID: 16641447)
1. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
Alvarez-Sala JL; Kardos P; Martínez-Beltrán J; Coronel P; Aguilar L
Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
4. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Weiss LR
Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
[TBL] [Abstract][Full Text] [Related]
5. Cefditoren pivoxil.
Darkes MJ; Plosker GL
Drugs; 2002; 62(2):319-36; discussion 337-8. PubMed ID: 11817976
[TBL] [Abstract][Full Text] [Related]
6. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
Zervos MJ; Heyder AM; Leroy B
J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Chodosh S; McCarty J; Farkas S; Drehobl M; Tosiello R; Shan M; Aneiro L; Kowalsky S
Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
[TBL] [Abstract][Full Text] [Related]
8. Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Zuck P; Petitpretz P; Geslin P; Rio Y; Leblanc F
Int J Clin Pract; 1999 Sep; 53(6):437-43. PubMed ID: 10622071
[TBL] [Abstract][Full Text] [Related]
9. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Shah PM; Maesen FP; Dolmann A; Vetter N; Fiss E; Wesch R
J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
[TBL] [Abstract][Full Text] [Related]
10. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
Wilson R; Langan C; Ball P; Bateman K; Pypstra R;
Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
[TBL] [Abstract][Full Text] [Related]
11. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective.
Rodríguez-Gascón A; Aguirre-Quiñonero A; Canut-Blasco A
Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):306-311. PubMed ID: 32085928
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
Johnson PA; Rodriguez HP; Wazen JJ; Huck W; Shan M; Tosiello R; Heyd A; Echols RM
J Otolaryngol; 1999 Feb; 28(1):3-12. PubMed ID: 10077777
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B
Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
Klein GL; Whalen E; Echols RM; Heyd A
J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
Haczyński J; Chyczewska E; Grzelewska-Rzymowska I; Malolepszy J; Marcinkowska-Suchowierska E; Milanowski J; Oklek K; Płusa T; Słominski J; Szmygin K; Rek M
Med Sci Monit; 2002 Jan; 8(1):PI1-7. PubMed ID: 11782685
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
[TBL] [Abstract][Full Text] [Related]
19. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
Gehanno P; Berche P
J Antimicrob Chemother; 1996 May; 37 Suppl A():105-14. PubMed ID: 8737130
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Siegert R; Berg O; Gehanno P; Leiberman A; Martinkenas JL; Nikolaidis P; Arvis P; Alefelder M; Reimnitz P
Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
